Several factors have been investigated which are of significance in the inactivation of PM2, a lipid-containing bacterial virus, by butylated hydroxytoluene (BHT). Studies of the time dependence of inactivation during exposure to BHT showed that virus killing occurs rapidly, with the majority of the effect taking place in the first 5 min. The degree of inactivation is dependent upon the initial virus titer, the solvent from which BHT is added, and the presence of a variety of protective agents, including surfactants, bovine serum albumin, and bacterial cells. Sucrose gradient analysis of 32P-labeled, BHT-treated virus was used to determine the degree to which the virion is disrupted by BHT. These experiments show that the 32P-labeled molecules are converted into very slowly sedimentable material by BHT treatment, indicating complete destruction of the virus particle.
Butylated hydroxytoluene (BHT) is a small, hydrophobic molecule ( Fig. 1 ) which is frequently used as an antioxidant. It is generally recognized as safe by the Food and Drug Administration (11) and is commonly added to foods to maintain freshness and prevent spoilage. We recently reported that BHT is a potent inactivator of the lipid-containing viruses PM2, 46, and herpes simplex virus (13) . It is effective, in vitro, at concentrations as low as 10-5 to 10-4 M, depending on the particular virus under study. These concentrations are in the range of those accumulated in the body fat of U.S. residents from dietary consumption of BHT as a food additive (2) .
The potential use of BHT as an antiviral agent has prompted us to investigate further its mode of action. In the present study we have characterized several factors that influence its inactivation of PM2, a lipid-containing bacterial virus. In addition, experiments were carried out to determine the degree to which the PM2 virion is disrupted upon treatment with BHT.
MATERIALS AND METHODS Virus and cells. Bacteriophage PM2 and its host, the marine bacterium Pseudomonas BAL-31, were discovered by Espejo and Canelo (5) . Our original stocks were provided by Eugene Cota-Robles (University of California, Santa Cruz). A thymine-requiring derivative of BAL-31, designated PS1001, was obtained by trimethoprim selection (14) . Its isolation and characteristics have been described (12) . From PS1001 we isolated a PM2-resistant mutent, designated RA1, for some of the present work. RAl was selected and characterized as a mutant that allows no detectable attachment of PM2 virus.
Media and culture methods. All experiments reported here were carried out in Medium 25, a chemically defined but somewhat enriched growth medium described previously (12) . Medium 25 is buffered to pH 7.6 with tris(hydroxymethyl)aminomethane. For growth of RA1, thymidine was added at 50 p,g/ ml.
Samples were assayed for infectious virus by the agar overlay method. Bottom agar contained Q medium (12) (13) , all samples were exposed to BHT for 30 min and then assayed, after dilution, for infectious virus. shows data for samples diluted and plated at different times of exposure to 0.1 mM BHT. The inactivation occurs rapidly, with the majority of the effect taking place in the first 5 min. Some variation is seen, both in the time course and in the maximum level of inactivation, when 0.1 mM BHT is used. Two experiments illustrate this point in Fig. 2 . When the concentration of BHT is increased to 0.2 mM, inactivation levels greater than 99% are consistently observed. The data in Fig. 2 Effect of cells on virus inactivation. We further investigated the possibility that cells can protect PM2 against BHT, making use of mutant RA1, a derivative of BAL-31 to which PM2 does not attach. Virus at an initial titer of 106 PFU/ml were exposed to 0.2 mM BHT with various concentrations of RAl present. The data, shown in Fig. 4 , indicate that 2 x 108 cells/ml reduce the inactivation by about 50%, whereas at cell concentrations less than 2 x 107/ ml no protective effect is observed.
Protective agents. Several agents were found to protect PM2 from BHT, including a number of surfactants and the protein bovine serum albumin. These data are summarized in Solvent effects. BHT has very low solubility in water but may be readily dissolved in ethanol, ether, acetone, dimethyl sulfoxide (Me,SO), and other organic solvents. We found that the inactivation of PM2 by 0.2 mM BHT is dependent upon the solvent from which the BHT is introduced into the medium. Solutions (20 mM) of BHT in several solvents were prepared, and these were added to a final concentration of 1% solvent, 0.2 mM BHT to viral samples as described above. The results are shown in Table 2 . Control experiments showed that PM2 is not inactivated by 1% solutions of BHT that result from mixing the ethanol solution with medium are the most effective at virus inactivation, and that these aggregate into larger, less effective structures upon standing.
Effect of BHT-treated virus on cell survival. Even though BHT-inactivated virus cannot form plaques on BAL-31, we considered the possibility that the inactive virus is capable of attaching to and killing the host cell. Many virus mutants, for example, can kill a nonpermissive host cell on which they cannot form plaques. A sample of PM2 was treated for 30 min with 0.2 mM BHT at an initial virus titer of 108 PFU/ml, resulting in about 84% inactivation. Three samples of BAL-31 at 6 x 107 colony-forming units (CFU)/ml were mixed with an equal volume of (i) medium, (ii) PM2 at 108 PFU/ml, or (iii) BHT-treated PM2. After 20 min, dilutions were plated for surviving bacteria. The results are shown in Table 3 . It is clear from these data that BHT-treated PM2 are not capable of killing the host cells. The 7% cell inactivation by BHT-treated PM2 is most likely due to the 16% virus that survived the BHT treatment.
Sucrose gradient analysis of BHT-treated virus. The experiments described here were undertaken to determine the degree to which the PM2 virus particle is disrupted by BHT treatment. This required the use of radioactively labeled, purified virus. We also used [3H]BHT in some of this work to obtain an estimate of the degree of binding of BHT to active virus particles when a BHT treatment resulting in only partial inactivation is administered.
PM2 lysates were prepared in the presence of 32PO4 and centrifuged at low speed to remove cell debris. The virus was pelleted, resuspended in a small volume of medium, and layered onto a sucrose gradient. Fractions were collected and assayed for radioactivity and PFU. Both 32P radioactivity and PFU appeared as a single band in the region of fraction 12. The peak fraction was diluted and used for further experiments.
In one experiment a 10-fold dilution of fraction 12 was treated for 30 min with 0.2 mM BHT containing 0.5 ,uCi of [3H]BHT per ml at final concentration. An untreated sample was maintained as a control. The BHT treatment Fig. 3 , because the initial virus titer was about 2.5 x 109 PFU/ml. The BHT-treated and control samples were analyzed on sucrose gradients; the results are shown in Fig. 6 . For the control, the 32p radioactivity forms a band centered about fraction 12, with very little radioactivity at the top of the gradient. Plating results showed that the peak ofvirus infectivity coincided with the peak of radioactivity. For the BHT-treated sample the peak at fraction 12 is diminished and a new band very near the top of the gradient appears. Plating results showed that the particles in the peak at fraction 12 are equally infectious as those for the control. These data indicate that BHT inactivates PM2 by completely disrupting the virion, releasing the 32P-labeled nucleic acid and phospholipid material into a form that will sediment no more than about 10% of the way down this gradient. BHT has a density less than that ofthe gradient solution, and the 3H radioactivity is located near the top of the gradient. It is interesting to note the absence of any detectable incorporation of [3H]BHT into the PM2 virus particles that survive the BHT treatment. We have quantified this using the data of Fig. 6 and the plating results. Our estimate is that the PM2 particles contain less than 105 BHT molecules/ PFU. It is not surprising, therefore, that we do not detect PM2-associated BHT in this way, in that 105 BHT molecules correspond to an amount equivalent in weight to about 50% that of the virus.
Additional and more convincing evidence that the PM2 particles are disrupted by BHT was obtained in a second experiment, in which the Fraction No .  FIG. 6 . Sucrose gradient analysis ofcontrol and BHT-treated PAD virus. The peak fraction from a purification gradient was diluted fivefold in Medium 25 and divided into two portions. One was treated for 30 min with [3H]BHT at a final concentration of02 mM and 0.5 IACi/ml by the procedure described in Fig. 2 ; the other was diluted twofold with medium and maintained as a control. One-milliliter samples were analyzed on sucrose gradients. Correction was made for 32p counts that are registered in the 3H channel ofthe counter. The peak fractions 10 through 14 had combined PFU of1.34 x 109and 1.08 x 109for the control and BHT-treated samples, respectively. (Inset) 3H radioactivity for fractions 9 through 17 on an expanded scale.
on November 3, 2017 by guest http://aac.asm.org/ Downloaded from virus sample was diluted 100-fold for BHT treatment. Under these conditions, the inactivation was greater than 99%. Figure 7 shows the sucrose gradient analysis of the BHTtreated sample and reveals that there are no detectable particles in the region of fraction 12. The 32P radioactivity is all located about three fractions from the top of the gradient in a very slowly sedimenting form.
Cell growth in the presence of BHT. Some experiments were carried out to determine the effect of BHT on growth of the host cell BAL-31. The concentration of BHT used was 0.2 mM, a level that inactivates greater than 99% of PM2 virus. A culture growing exponentially was divided into two parts, and one was treated with BHT by the same procedure used to treat virus. Initially, as is seen in Fig.  8 , the absorbance of the BHT-treated culture is quite high but drops rapidly to that of the control. This initial high absorbance is due to the turbidity of the BHT microcrystals that form when the ethanol-BHT solution is added to the medium. Within 30 min, most of the turbidity due to the BHT has disappeared as the microcrystals aggregate into larger particles that float to the top. Afterwards, the absorbance measurements show that the BHT-treated cells grow at a rate that is identical, within experimental error, to the control.
At several times during the experiment, samples were diluted and plated for colonies. These data, shown in the upper portion of Fig.  8 , confirm the lack of any significant effect of BHT on the survival or growth of the host cell. Additional plating experiments on more dilute cell cultures (data not shown) established that 0.2 mM BHT is not toxic to BAL-31 at cell concentrations as low as 103 CFU/ml.
Uptake of BHT by host cells. Low-speed sucrose gradient analysis was used to provide some estimate of the degree to which BHT is taken up by or becomes associated with the host cell. These experiments were prompted by the observation (Fig. 4) that cells can protect the virus against inactivation by BHT. To facilitate rapid location of the cells on the gradient, the culture was briefly labeled with 32P. The labeled cells were centrifuged and washed twice with medium to remove unincorporated radioactivity. After treatment with 0.2 mM BHT containing [3H]BHT for 30 min, the culture was analyzed on a sucrose gradient, as described in Materials and Methods. Figure 9 shows the results of an experiment in which the cell concentration during exposure to BHT was 6 x 107 CFU/ml. A well-defined band of 32P radioactivity shows the location of cells on the gradient, and plating results gave a coincident peak for CFU. It can be seen from the 3H radioactivity that an insignificant amount of BHT has been taken up by or irreversibly associated with the cells. We estimate that no more than 7%, and most likely much less, of the total BHT is cell associated in this experiment.
In another experiment, where the cell concentration during exposure to BHT was 6 x 108 CFU/ml, less than 10% of the BHT was associated with the cells. This is a cell concentration that can protect PM2 virus from inactivation by BHT (Fig. 3) . These data are seemingly contradictory, but may be explainable in the following small fraction of the total BHT from solution. DISCUSSION The bacterial virus PM2 contains a lipid bilayer as an integral part of its structure (9) . The virion contains four major structural proteins (3) and a circular, double-stranded deoxyribonucleic acid molecule (6) . An inner core, which can be isolated under certain conditions, is composed of two proteins and the viral deoxyribonucleic acid (10) 8, 1975 tein coat, icosahedral in shape, is located (9) . Protein spikes, thought to be the means by which PM2 attaches to its host cell, protrude from the virion. The particle diameter is about 60 nm (5) .
The presence of a lipid bilayer in PM2 makes this virus susceptible to many organic solvents, as are a variety of lipid-containing animal viruses. BHT, being a hydrophobic, bulky molecule nearly spherical in shape, is expected and has been found (4) to have perturbing effects on membrane structures. Nevertheless, BHT has an apparent low level of toxicity to cells, a conclusion supported by some of the work presented here. Its effective inactivation of lipidcontaining viruses may therefore be of some potential importance.
One aspect of the work reported here was a characterization of several factors that influence the antiviral activity of BHT. This was carried out, to some extent, to provide a rational basis for further experiments with other systems. From our experiments it is clear that a number of factors must be considered when studying the antiviral activity of BHT. For inactivation of PM2, the action takes place within a few minutes after virus is added to a BHT suspension. The degree of inactivation is dependent on the initial virus titer, the solvent from which BHT is added, and the presence of a variety of "protectors," including surfactants, bovine serum albumin, and bacterial cells. Suspensions of BHT are most active against PM2 immediately after they are prepared and lose their effectiveness on standing.
Many of these experiments support the point of view that only a small portion of the BHT suspension prepared by our procedure, most likely very small microcrystalline particles, are effective for inactivating PM2. First, the degree of turbidity produced when the BHT suspension is formed from different solvents ( Table 2) seems related to inactivation efficiency. Second, surfactants which reduce the turbidity, presumably by solubilizing the BHT, protect PM2 against inactivation (Table 1) . Third, the loss of antiviral activity of a BHT suspension upon standing can be explained by the aggregation of these active microcrystals into larger structures (Fig. 5) . This is observed as a decrease in turbidity. And fourth, the observation that cells can protect PM2 under conditions where only a small fraction of the total BHT is taken up by or adsorbed to the cells strongly suggests that only a small fraction of the BHT is participating in virus inactivation. Further evidence along these lines was provided by experiments (data not presented) in which the BHT suspension was passed through a 0.22-,um filter INACTIVATION OF PM2 BY BHT 705 before adding to the virus. The filtration removed the larger BHT crystals, including a good part of the light-scattering material. 3H radioactivity counts showed that only 20% of the total BHT passed through the filter. However, the filtered solution was still active against PM2. A second aspect of this work was a study, using sucrose gradient analysis, of the means by which BHT inactivates PM2. The results show that BHT-treated virus is so disrupted that the viral material sediments only about 10% of the way down the gradient. The sedimentation coefficient of the inner core of PM2 has been reported as 133S, as compared to 290S for the complete particle (8) . From these values we can estimate, in rough approximation, that inner cores would sediment to the region of fraction 24 in our gradient. Viral deoxyribonucleic acid, on the other hand, has a sedimentation coefficient of about 28S (7) and should sediment to the region of fractions 30 and 31 on our gradient. We conclude, on this basis, that the inner core of PM2 is not intact after BHT treatment, that the particle structure is completely disrupted under these conditions, and that the band near the top of the gradient is largely the released viral deoxyribonucleic acid.
The mechanism of BHT inactivation may well be different with other viruses. For example, work in progress with 46, an enveloped bacterial virus that is extremely susceptible to BHT, indicates that this virus is not totally disrupted, but that the BHT-treated particles cannot attach to the host cells.
